Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

Tacrolimus prevents breast cancer growth in pre-clinical studies

Tacrolimus prevents breast cancer growth in pre-clinical studies

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Dr. Reddy's 2011 consolidated revenues increase 6% to Rs. 74.7 billion

Dr. Reddy's 2011 consolidated revenues increase 6% to Rs. 74.7 billion

BMY to present belatacept Phase III new data at American Transplant Congress

BMY to present belatacept Phase III new data at American Transplant Congress

Results of study evaluating potential inhibitory effects of PPIs on Plavix presented at ACC 2011

Results of study evaluating potential inhibitory effects of PPIs on Plavix presented at ACC 2011

Smoking withdrawal after liver transplantation may protect against neoplasia development

Smoking withdrawal after liver transplantation may protect against neoplasia development

Smoking cessation after liver transplantation reduces incidence of malignancy

Smoking cessation after liver transplantation reduces incidence of malignancy

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

FDA approves Mylan's generic Prograf Capsules ANDA

FDA approves Mylan's generic Prograf Capsules ANDA

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor